AAPL   322.10 (+0.08%)
MSFT   183.63 (+0.44%)
FB   229.85 (-0.89%)
GOOGL   1,433.99 (-0.06%)
AMZN   2,468.60 (-0.10%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
NFLX   424.26 (-0.39%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
AAPL   322.10 (+0.08%)
MSFT   183.63 (+0.44%)
FB   229.85 (-0.89%)
GOOGL   1,433.99 (-0.06%)
AMZN   2,468.60 (-0.10%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
NFLX   424.26 (-0.39%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
AAPL   322.10 (+0.08%)
MSFT   183.63 (+0.44%)
FB   229.85 (-0.89%)
GOOGL   1,433.99 (-0.06%)
AMZN   2,468.60 (-0.10%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
NFLX   424.26 (-0.39%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
AAPL   322.10 (+0.08%)
MSFT   183.63 (+0.44%)
FB   229.85 (-0.89%)
GOOGL   1,433.99 (-0.06%)
AMZN   2,468.60 (-0.10%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
NFLX   424.26 (-0.39%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
Log in

NASDAQ:CARACara Therapeutics Insider Trades

$15.76
+0.08 (+0.51 %)
(As of 06/2/2020 02:27 PM ET)
Add
Compare
Today's Range
$15.50
Now: $15.76
$15.98
50-Day Range
$13.72
MA: $15.17
$16.46
52-Week Range
$8.88
Now: $15.76
$27.55
Volume18,008 shs
Average Volume574,222 shs
Market Capitalization$737.57 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86

Insider Trades

Cara Therapeutics (NASDAQ:CARA) Insider Buying and Selling Activity

Insider Ownership Percentage: 5.80%

Insider Buying and Selling by Quarter


Cara Therapeutics (NASDAQ CARA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/22/2020Derek T ChalmersCEOSell371$16.00$5,936.00975,292  
5/20/2020Derek T ChalmersCEOSell1,200$16.00$19,200.00975,292  
5/12/2020Derek T ChalmersCEOSell4,929$16.00$78,864.00976,492  
5/12/2020Jeffrey L IvesDirectorSell2,500$16.00$40,000.008,500  
4/21/2020Derek T ChalmersCEOSell6,348$15.56$98,774.88987,769  
4/21/2020Frederique Ph.D. MenzaghiSVPSell12,894$15.58$200,888.52117,386  
4/21/2020Jeffrey L IvesDirectorSell2,500$16.00$40,000.008,500  
4/21/2020Scott TerrillionInsiderSell2,721$15.56$42,338.7641,103  
3/4/2020Jeffrey L IvesDirectorSell2,500$16.00$40,000.008,500  
1/2/2020Derek T ChalmersCEOSell10,000$16.05$160,500.00917,769  
1/2/2020Jeffrey L IvesDirectorSell2,500$16.13$40,325.008,500  
12/4/2019Derek T ChalmersCEOSell10,699$17.05$182,417.95918,468  
12/4/2019Mani MohindruCFOSell4,755$17.05$81,072.7522,196  
12/4/2019Scott TerrillionInsiderSell3,980$17.05$67,859.0020,749  
12/2/2019Derek T ChalmersCEOSell10,000$25.79$257,900.00918,468  
12/2/2019Jeffrey L IvesDirectorSell2,500$25.83$64,575.008,500  
11/1/2019Derek T ChalmersCEOSell5,000$20.79$103,950.00928,468  
11/1/2019Jeffrey L IvesDirectorSell2,500$20.68$51,700.008,500  
10/25/2019Frederique Ph.D. MenzaghiSVPSell4,000$19.91$79,640.0063,886  
10/18/2019Frederique Ph.D. MenzaghiSVPSell4,000$19.33$77,320.0067,886  
10/11/2019Frederique Ph.D. MenzaghiSVPSell4,000$18.70$74,800.0071,886  
10/4/2019Frederique Ph.D. MenzaghiSVPSell4,000$19.19$76,760.0075,886  
10/1/2019Derek T ChalmersCEOSell10,000$18.28$182,800.00933,468  
10/1/2019Jeffrey L IvesDirectorSell2,500$18.21$45,525.008,500  
9/3/2019Derek T ChalmersCEOSell5,000$23.26$116,300.00943,468  
9/3/2019Frederique Ph.D. MenzaghiSVPSell20,000$22.92$458,400.0079,886  
9/3/2019Jeffrey L IvesDirectorSell2,500$23.31$58,275.008,500  
8/1/2019Derek T ChalmersCEOSell10,000$23.27$232,700.00948,468  
8/1/2019Frederique Ph.D. MenzaghiSVPSell20,000$23.24$464,800.0099,886  
8/1/2019Jeffrey L IvesDirectorSell2,500$23.24$58,100.008,500  
7/17/2019Frederique Ph.D. MenzaghiInsiderSell8,996$27.50$247,390.00119,886  
7/15/2019Mani MohindruCFOSell37,431$25.00$935,775.0051,294  
7/1/2019Frederique Ph.D. MenzaghiInsiderSell20,000$21.90$438,000.00128,882  
7/1/2019Jeffrey L IvesDirectorSell2,500$21.75$54,375.008,500  
5/29/2019Derek T ChalmersCEOSell5,528$21.42$118,409.76963,996  
5/29/2019Frederique Ph.D. MenzaghiInsiderSell11,397$21.19$241,502.43160,279  
5/29/2019Mani MohindruCFOSell2,496$21.39$53,389.4416,359  
3/13/2019Frederique Ph.D. MenzaghiInsiderSell20,000$18.65$373,000.00139,582  
3/13/2019Mani MohindruCFOSell16,041$19.12$306,703.9224,067  
3/1/2019Derek T ChalmersCEOSell9,792$17.04$166,855.68943,996  
2/28/2019Frederique Ph.D. MenzaghiSVPSell1,500$17.50$26,250.00142,779  
2/25/2019Frederique Ph.D. MenzaghiSVPSell2,200$17.50$38,500.00144,279  
2/1/2019Derek T ChalmersCEOSell20,000$14.99$299,800.00953,788  
1/4/2019Derek T ChalmersCEOSell20,000$13.61$272,200.00  
12/28/2018Derek T ChalmersCEOSell15,825$12.53$198,287.25993,788  
12/28/2018Derek T ChalmersCEOSell15,825$12.53$198,287.25  
12/28/2018Frederique Ph.D. MenzaghiSVPSell4,300$12.53$53,879.00  
12/28/2018Frederique Ph.D. MenzaghiSVPSell4,300$12.53$53,879.00146,479  
12/28/2018Mani MohindruCFOSell4,500$12.55$56,475.008,026  
12/28/2018Mani MohindruCFOSell4,500$12.55$56,475.00  
12/28/2018Scott TerrillionInsiderSell3,100$12.51$38,781.006,386  
12/28/2018Scott TerrillionInsiderSell3,100$12.51$38,781.00  
11/15/2018Mani MohindruCFOSell16,042$18.50$296,777.00  
11/1/2018Derek T ChalmersCEOSell20,000$18.78$375,600.00991,392  
11/1/2018Frederique Ph.D. MenzaghiSVPSell3,000$18.77$56,310.00145,000  
10/17/2018Joseph William StaufferInsiderSell11,442$20.13$230,327.462,970  
10/17/2018Mani MohindruCFOSell16,042$20.19$323,887.9816,042  
10/1/2018Derek T ChalmersCEOSell20,000$23.79$475,800.00  
10/1/2018Frederique Ph.D. MenzaghiSVPSell3,000$23.99$71,970.00  
9/4/2018Derek T ChalmersCEOSell20,000$19.71$394,200.001,031,392  
9/4/2018Frederique Ph.D. MenzaghiSVPSell3,000$19.81$59,430.0098,000  
8/20/2018Frederique Ph.D. MenzaghiSVPSell3,000$18.89$56,670.00101,000  
7/10/2018Derek T ChalmersCEOSell20,000$20.64$412,800.001,051,392  
7/2/2018Frederique Ph.D. MenzaghiSVPSell3,000$19.00$57,000.00104,000  
6/1/2018Frederique Ph.D. MenzaghiSVPSell3,000$15.49$46,470.00107,000  
5/23/2018Frederique Ph.D. MenzaghiSVPSell9,000$15.19$136,710.00110,000  
2/16/2018Derek T ChalmersCEOSell5,400$15.00$81,000.001,071,392  
2/15/2018Frederique Ph.D. MenzaghiSVPSell3,000$15.02$45,060.00119,000  
1/24/2018Derek T ChalmersCEOSell12,500$15.00$187,500.001,073,792  
1/24/2018Frederique Ph.D. MenzaghiSVPSell15,000$15.00$225,000.00122,000  
11/1/2017Derek T ChalmersCEOSell16,000$12.66$202,560.001,066,292  
7/14/2017Derek T ChalmersCEOSell25,000$15.05$376,250.001,107,292  
7/14/2017Frederique Ph.D. MenzaghiVPSell3,000$15.00$45,000.00120,000  
6/29/2017Dean SlagelDirectorSell250,000$25.87$6,467,500.00  
3/31/2017Ventures Vi Lp RhoMajor ShareholderBuy500,000$18.19$9,095,000.00  
4/20/2016Frederique Ph.D. MenzaghiVPSell6,000$9.00$54,000.00123,000  
3/17/2016Ventures Vi Lp RhoMajor ShareholderBuy400,000$4.87$1,948,000.00  
2/3/2016Frederique Ph.D. MenzaghiVPSell6,000$9.04$54,240.00129,000  
1/26/2016Michael E LewisInsiderSell7,262$10.93$79,373.66314,988  
1/6/2016Derek T ChalmersCEOSell12,500$17.22$215,250.001,087,292  
12/1/2015Frederique Ph.D. MenzaghiVPSell6,000$16.21$97,260.00141,000  
11/2/2015Frederique Ph.D. MenzaghiVPSell6,000$14.26$85,560.00147,000  
10/1/2015Frederique Ph.D. MenzaghiVPSell6,000$13.95$83,700.00153,000  
9/1/2015Frederique Ph.D. MenzaghiVPSell7,000$18.63$130,410.00159,000  
8/18/2015Josef SchoellCFOBuy3,000$22.10$66,300.0028,000  
6/1/2015Michael E LewisInsiderSell7,262$9.50$68,989.00  
5/19/2015Dean SlagelDirectorSell188,811$10.02$1,891,886.22  
4/1/2015Michael E LewisInsiderSell7,262$9.90$71,893.80  
3/2/2015Michael E LewisInsiderSell7,262$10.11$73,418.82  
2/2/2015Michael E LewisInsiderSell7,262$10.60$76,977.20  
2/5/2014Ventures Vi Lp RhoMajor ShareholderBuy225,818$11.00$2,483,998.00  
(Data available from 1/1/2013 forward)
This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.